Mounjaro vs Ozempic UK: What’s the Difference? (2026 Guide)
Two of the most searched injectable treatments in the UK right now are Mounjaro and Ozempic. Both contain ingredients that work on GLP-1 receptors, both are once-weekly injections, and both are regularly discussed in the context of weight management. But they are not the same thing — and the differences matter.
Here’s a clear, no-jargon comparison of Mounjaro vs Ozempic UK to help you understand which may be relevant to your situation.
The Key Difference: What They’re Approved For
This is the most important distinction:
- Mounjaro (Tirzepatide) is MHRA-approved in the UK for chronic weight management in adults with a BMI of 30+ (or 27+ with a weight-related condition)
- Ozempic (Semaglutide 0.5mg/1mg) is MHRA-approved in the UK for type 2 diabetes management — not weight loss
If your primary goal is weight loss and you do not have type 2 diabetes, Mounjaro (or Wegovy) is the appropriate licensed treatment. Ozempic is a diabetes medication that happens to have weight-related effects as a secondary outcome.
How Do They Work?
Mounjaro activates both GIP and GLP-1 receptors — a dual-action mechanism that makes it unique among currently available injectable treatments. This combination reduces appetite, slows digestion and supports blood sugar regulation simultaneously.
Ozempic activates GLP-1 receptors only. This is the same mechanism as Wegovy (which is Semaglutide at a higher dose), producing similar but generally less pronounced effects on appetite and weight compared to Mounjaro.
Effectiveness Comparison
For weight loss specifically, clinical data favours Mounjaro:
- Mounjaro — average weight loss of 20–22% of body weight at 15mg dose over 72 weeks
- Ozempic — not primarily studied for weight loss; the weight loss version (Semaglutide 2.4mg) is branded as Wegovy, which shows ~15% average weight loss
For blood sugar management in type 2 diabetes, both Mounjaro and Ozempic are effective — but Ozempic has a longer track record specifically in this indication.
Side Effects
Both share similar GLP-1 related side effects:
- Nausea
- Vomiting
- Diarrhoea
- Constipation
- Reduced appetite
- Stomach discomfort
Mounjaro’s additional GIP action may offer slightly better tolerability for some patients, though this varies individually.
Cost Comparison
At MedExpress:
- Mounjaro from £129 per month
- Ozempic from £99 per month
Which is Right for You?
| Mounjaro | Ozempic | |
|---|---|---|
| Active ingredient | Tirzepatide | Semaglutide |
| UK approval | Weight management | Type 2 diabetes |
| Receptor targets | GIP + GLP-1 | GLP-1 only |
| Primary use | Weight loss | Blood sugar control |
| Starting price | £129/month | £99/month |
If you have type 2 diabetes and need blood sugar management, Ozempic is the appropriate choice. If your goal is weight loss, Mounjaro is the licensed and clinically superior option.
👉 Buy Mounjaro UK — from £129 👉 Buy Ozempic Online UK — from £99
